140 related articles for article (PubMed ID: 12963837)
21. Helicobacter pylori increases proteasome-mediated degradation of p27(kip1) in gastric epithelial cells.
Eguchi H; Herschenhous N; Kuzushita N; Moss SF
Cancer Res; 2003 Aug; 63(15):4739-46. PubMed ID: 12907657
[TBL] [Abstract][Full Text] [Related]
22. Kip1 degradation via the ubiquitin-proteasome pathway.
Tam SW; Theodoras AM; Pagano M
Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
[TBL] [Abstract][Full Text] [Related]
23. Moving protein heads for breakdown.
Scheffner M
Nature; 1999 Mar; 398(6723):103-4. PubMed ID: 10086352
[No Abstract] [Full Text] [Related]
24. Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, early D-type cyclins, Bax, and caspase-dependent and -independent pathways.
Bogner C; Schneller F; Hipp S; Ringshausen I; Peschel C; Decker T
Exp Hematol; 2003 Mar; 31(3):218-25. PubMed ID: 12644019
[TBL] [Abstract][Full Text] [Related]
25. The prognostic and therapeutic relevance of p27kip1 in Ewing's family tumors.
Matsunobu T; Tanaka K; Matsumoto Y; Nakatani F; Sakimura R; Hanada M; Li X; Oda Y; Naruse I; Hoshino H; Tsuneyoshi M; Miura H; Iwamoto Y
Clin Cancer Res; 2004 Feb; 10(3):1003-12. PubMed ID: 14871979
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-beta inhibition of proteasomal activity: a potential mechanism of growth arrest.
Tadlock L; Yamagiwa Y; Hawker J; Marienfeld C; Patel T
Am J Physiol Cell Physiol; 2003 Aug; 285(2):C277-85. PubMed ID: 12646415
[TBL] [Abstract][Full Text] [Related]
27. The ubiquitin-proteasome pathway in cancer.
Spataro V; Norbury C; Harris AL
Br J Cancer; 1998; 77(3):448-55. PubMed ID: 9472642
[TBL] [Abstract][Full Text] [Related]
28. Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells.
Kitagawa H; Tani E; Ikemoto H; Ozaki I; Nakano A; Omura S
FEBS Lett; 1999 Jan; 443(2):181-6. PubMed ID: 9989601
[TBL] [Abstract][Full Text] [Related]
29. Inducible p27(Kip1) expression inhibits proliferation of K562 cells and protects against apoptosis induction by proteasome inhibitors.
Drexler HC; Pebler S
Cell Death Differ; 2003 Mar; 10(3):290-301. PubMed ID: 12700629
[TBL] [Abstract][Full Text] [Related]
30. Facilitation of proteasomal degradation of p27Kip1 by N-terminal cleavage and their sequence requirements.
Hirano K; Ihara E; Hirano M; Nishimura J; Nawata H; Kanaide H
FEBS Lett; 2004 Sep; 574(1-3):111-5. PubMed ID: 15358549
[TBL] [Abstract][Full Text] [Related]
31. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase.
Malek NP; Sundberg H; McGrew S; Nakayama K; Kyriakides TR; Roberts JM
Nature; 2001 Sep; 413(6853):323-7. PubMed ID: 11565035
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms underlying IGF-I-induced attenuation of the growth-inhibitory activity of trastuzumab (Herceptin) on SKBR3 breast cancer cells.
Lu Y; Zi X; Pollak M
Int J Cancer; 2004 Jan; 108(3):334-41. PubMed ID: 14648698
[TBL] [Abstract][Full Text] [Related]
33. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.
Loda M; Cukor B; Tam SW; Lavin P; Fiorentino M; Draetta GF; Jessup JM; Pagano M
Nat Med; 1997 Feb; 3(2):231-4. PubMed ID: 9018245
[TBL] [Abstract][Full Text] [Related]
34. The proteasome controls the expression of a proliferation-associated nuclear antigen Ki-67.
Wu Y; Luo H; Kanaan N; Wu J
J Cell Biochem; 2000 Jan; 76(4):596-604. PubMed ID: 10653979
[TBL] [Abstract][Full Text] [Related]
35. The proteasome: a novel therapeutic target in haematopoietic malignancy.
Magill L; Walker B; Irvine AE
Hematology; 2003 Oct; 8(5):275-83. PubMed ID: 14530169
[TBL] [Abstract][Full Text] [Related]
36. Role of proteasomes in T cell activation and proliferation.
Wang X; Luo H; Chen H; Duguid W; Wu J
J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1.
Nakayama KI; Hatakeyama S; Nakayama K
Biochem Biophys Res Commun; 2001 Apr; 282(4):853-60. PubMed ID: 11352628
[TBL] [Abstract][Full Text] [Related]
38. Cloning and functional expression of a degradation-resistant novel isoform of p27Kip1.
Hirano K; Hirano M; Zeng Y; Nishimura J; Hara K; Muta K; Nawata H; Kanaide H
Biochem J; 2001 Jan; 353(Pt 1):51-57. PubMed ID: 11115398
[TBL] [Abstract][Full Text] [Related]
39. Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling.
Tsutsumi S; Yanagawa T; Shimura T; Fukumori T; Hogan V; Kuwano H; Raz A
J Biol Chem; 2003 Aug; 278(34):32165-72. PubMed ID: 12783864
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
Vlach J; Hennecke S; Amati B
EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
